In the 2021 WHO classification, wild-type IDH has become a prerequisite for diagnosing GBM, and the term “GBM, IDH-wildtype” is now specifically applied to define this subset of adult-type diffuse gliomas. This evidence concerns the gene IDH2 and glioblastoma.